Future studies will be geared towards understanding the regulatory mechanisms that control Mist1 expression in both AP and PDAC disease states with a long-term goal of devising strategies to modulate transcriptional networks that could alleviate clinical symptoms in patients diagnosed with pancreatitis and pancreatic cancer. The gene discussed is BHLHA15; the disease is familial pancreatic carcinoma.